Morphea Presenting as Widespread Oedema

Amoura Z. , Papo T. , Ninet J. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med 1997; 103: 514–19

von Bierbrauer A. , Barth P. , Willert J. , Baerwald C. , Mennel H.D. , Schmidt J.A. Electron microscopy and capillaroscopically guided nailfold biopsy in connective tissue diseases: detection of ultrastructural changes of the microcirculatory vessels. Br J Rheumatol 1998; 37: 1272–8

Denton C.P. , Abraham D.J. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 2001; 13: 505–11

Herrlinger K.R. , Noftz M.K. , Fellermann K. , Schmidt K. , Steinhoff J. , Stange E.F. Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use. Aliment Pharmacol Ther 2001; 15: 363–9

Pittau E. , Passiu G. , Mathieu A. Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging. Joint Bone Spine 2000; 67: 544–9

Englert H. , Low S. Pitting oedema in early diffuse systemic scleroderma. Ann Rheum Dis 2001; 60: 1079–80

Baluna R. , Vitetta E.S. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 1997; 37: 117–32

Assaly R. , Olson D. , Hammersley J. Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome. Chest 2001; 120: 1301–8

Sapadin A.N. , Fleischmajer R. Treatment of scleroderma. Arch Dermatol 2002; 138: 99–105

van den Hoogen F.H. , Boerbooms A.M. , Swaak A.J. , Rasker J.J. , van Lier H.J. , van de Putte L.B. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol 1996; 35: 364–72